Abstract Through microarray analyses, we identified the Mpped2 gene as differentially expressed in two neuroblastoma cell lines induced to differentiation with all-trans retinoic acid. Mpped2 codes for a new metallophosphodiesterase protein, the expression of which inhibits cell proliferation and soft agar colony formation in SH -SY5Y cells. This inhibition is concomitant to an increased proportion of the cells in G0/G1 phase and enhanced caspase 3 activation, effects not seen for the other phosphodiesterases. A Mpped2-null mutation (H67R) abrogates these functions, which indicates that the biochemical activity of Mpped2 is advantageous for cancer suppression. Expression analyses in the "Los Angeles" and "Essen" neuroblastoma gene-array data sets show that increased expression of Mpped2 is associated with good patient prognosis according to Kaplan-Meier analyses. Tumorigenic assays in mice show that overexpression of Mpped2 improves survival rate, substantially impairs tumor growth and induces neuronal differentiation. Altogether, these data show that Mpped2 expression impairs neuroblastoma tumorigenesis, and they establish a basis for future therapeutic applications.

The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastoma / Liguori, L; Andolfo, I; De Antonellis, P; Aglio, V; di Dato, V; Marino, N; Ivan Orlotti, N; De Martino, D; Capasso, Mario; Petrosino, G; Schramm, A; Navas, Luigi; Paolo Tonini, G; Eggert, A; Iolascon, Achille; Zollo, Massimo. - In: CELL CYCLE. - ISSN 1538-4101. - STAMPA. - 3:11(2012), pp. 1-13. [10.4161/cc.11.3.19063]

The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastoma.

Andolfo I;De Antonellis P;CAPASSO, Mario;NAVAS, LUIGI;IOLASCON, ACHILLE;ZOLLO, MASSIMO
2012

Abstract

Abstract Through microarray analyses, we identified the Mpped2 gene as differentially expressed in two neuroblastoma cell lines induced to differentiation with all-trans retinoic acid. Mpped2 codes for a new metallophosphodiesterase protein, the expression of which inhibits cell proliferation and soft agar colony formation in SH -SY5Y cells. This inhibition is concomitant to an increased proportion of the cells in G0/G1 phase and enhanced caspase 3 activation, effects not seen for the other phosphodiesterases. A Mpped2-null mutation (H67R) abrogates these functions, which indicates that the biochemical activity of Mpped2 is advantageous for cancer suppression. Expression analyses in the "Los Angeles" and "Essen" neuroblastoma gene-array data sets show that increased expression of Mpped2 is associated with good patient prognosis according to Kaplan-Meier analyses. Tumorigenic assays in mice show that overexpression of Mpped2 improves survival rate, substantially impairs tumor growth and induces neuronal differentiation. Altogether, these data show that Mpped2 expression impairs neuroblastoma tumorigenesis, and they establish a basis for future therapeutic applications.
2012
The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastoma / Liguori, L; Andolfo, I; De Antonellis, P; Aglio, V; di Dato, V; Marino, N; Ivan Orlotti, N; De Martino, D; Capasso, Mario; Petrosino, G; Schramm, A; Navas, Luigi; Paolo Tonini, G; Eggert, A; Iolascon, Achille; Zollo, Massimo. - In: CELL CYCLE. - ISSN 1538-4101. - STAMPA. - 3:11(2012), pp. 1-13. [10.4161/cc.11.3.19063]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/417347
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 24
social impact